A study of maternal outcome in heart disease in pregnancy in a tertiary care centre

Authors

  • Vilas N. Kurude Department of Obstetrics and Gynaecology, Grant Government Medical College and JJ Group of Hospitals, Mumbai, Maharashtra, India
  • Shruti U. Raut Department of Obstetrics and Gynaecology, Grant Government Medical College and JJ Group of Hospitals, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20223482

Keywords:

Rheumatic heart disease, Congenital heart disease, Complications, Cardiac failure, Outcome

Abstract

Background: Cardiovascular disease in women is associated with 4% complications during pregnancy and is the most frequent leading cause of maternal mortality reaching up to 15%. It stands third among the most common causes of maternal mortality after obstetric haemorrhage and preeclampsia respectively.The objective of this study is to study the maternal outcome of heart disease in pregnancy.

Methods: An Observational study was conducted over a period of 8 months over 50 antenatal patients with heart disease from January 2020 to August 2020 in the department of obstetrics and gynaecology, grant government medical college and JJ group of hospitals, Mumbai with appropriate inclusion and exclusion criteria. Prevalence of congenital and acquired heart disease complicating pregnancy, complications, age wise and parity wise distribution were mainly studied.

Results: The incidence of heart disease was 1.8% amongst the 2,750 total deliveries conducted. In this study 46 (92%) were registered and 4 (8%) were unregistered antenatal cases. 45 (90%) belonged to upper lower class and lower class as per Kupuswamy scale with poor nutrition and antenatal care. 34 (68%) of patients had rheumatic heart disease and 11 (22%) patients had congenital heart disease. Mitral stenosis was found to be the dominant valvular lesion in rheumatic heart disease in 12 (24%) cases. Over 25 (50%) of the patients had normal vaginal delivery and 9 (18%) had instrumental vaginal deliveries, 7 (14%) with vacuum and 2 (4%) with forceps. Congestive cardiac failure was found to be the major complication found in 4 (3.9%) cases. About 8 (16%) patients required intensive care unit admission. Maternal maternity is about 4% (2 patients) in the present study.

Conclusions: Maternal mortality in heart disease patients can be brought down significantly by effective preconceptional counselling, and improvements in medical, surgical, antenatal, intranatal, and postnatal care and effective motivation for contraception.


 

References

Van Hagen IM, Boersma E, Johnson MR, Thorne SA, Parsonage WA, Escribano Subias P, et al. Global cardiac risk assessment in the registry of pregnancy and cardiac disease: results of a registry from the European society of cardiology. Eur J Heart Failure. 2016;18(5):523-33.

Roos-Hesselink J, Baris L, Johnson M, De Backer J, Otto C, Marelli A, et al. Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC registry of pregnancy and cardiac disease (ROPAC). Eur Heart J. 2019;40(47): 3848-55.

Thorne S. Pregnancy and native heart valve disease. Heart. 2016;102(17):1410

Reimold SC, Rutherford JD. Valvular heart disease in pregnancy. New Eng J Med. 2003;349(1):52-9.

Rizvi SF, Khan MA, Kundi A, Marsh DR, Samad A, Pasha O. Status of rheumatic heart disease in rural Pakistan. Heart. 2004;90(4):394-9.

Sani MU, Karaye KM, Borodo MM. Prevalence and pattern of rheumatic heart disease in the Nigerian savannah: an echocardiographic study. Cardiovasc J Afr. 2007;18(5):295.

Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the top end of Australia's Northern Territory. Med J Australia. 1996;164(3):146-9.

Ozer O, Davutoglu V, Sari I, Akkoyun DC, Sucu M. The spectrum of rheumatic heart disease in the southeastern Anatolia endemic region: results from 1900 patients. J Heart Valve Dis. 2009;18(1):68-72.

Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and characteristics of newly diagnosed rheumatic heart disease in urban African adults: insights from the heart of Soweto study. Eur Heart J. 2010;31(6):719-27.

Shrestha NR, Pilgrim T, Karki P, Bhandari R, Basnet S, Tiwari S, et al. Rheumatic heart disease revisited: patterns of valvular involvement from a consecutive cohort in eastern Nepal. J Cardiovasc Med. 2012; 13(11):755-9.

Mudaliar AL. Mudaliar and Menon's clinical obstetrics. Orient Blackswan. 2005.

Chia YT, Yeoh SC, Viegas OA, Lim M, Ratnam SS. Maternal congenital heart disease and pregnancy outcome. J Obstet Gynaecol Res. 1996;22(2):185-91

De Swiet M, Fidler J. Heart disease in pregnancy: some controversies. J Obstet Gynaecol Res. 2003;21(3):123-7.

William’s Obstetrics. 21st ed. Netherlands: Elsevier; 2000.

Ramlakhan KP, Johnson MR, Roos-Hesselink JW. Pregnancy and cardiovascular disease. Nat Rev Cardiol. 2020;17(11):718-31.

Sawhney H, Aggarwal N, Suri V, Vasishta K, Sharma Y, Grover A. Maternal and perinatal outcome in rheumatic heart disease. Int J Gynecol Obstet. 2003;80(1):9-14.

Bhatla N, Lal S, Behera G, Kriplani A, Mittal S, Agarwal N, et al. Cardiac disease in pregnancy. Int J Gynecol Obstet. 2003;82(2):153-9.

Jacob S, Bloebaum L, Varner MW. Maternal mortality in Utah. Obstet Gynecol. 1998;91(2):187-91.

Downloads

Published

2022-12-28

Issue

Section

Original Research Articles